A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
- Journal
- Nature Medicine
In The Last Decade
doi.org/10.1038/nm1377 →Countries where authors are citing A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
This map shows the geographic impact of A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells more than expected).
Fields of papers citing A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
This network shows the impact of A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells.
About A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
This paper, published in 2006, received 722 indexed citations . Written by Ju‐Seog Lee, Jeonghoon Heo, Louis Libbrecht, In‐Sun Chu, Pál Kaposi-Novák, Diego F. Calvisi, Arsen Mikaelyan, Lewis R. Roberts, Anthony J. Demetris and Zongtang Sun covering the research area of Oncology, Molecular Biology and Hepatology. It is primarily cited by scholars working on Molecular Biology (360 citations), Hepatology (359 citations) and Cancer Research (234 citations). Published in Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1038/nm1377.